Developer docs
API playgroundTry for free, no card

Search company profiles

Lorient Capital

Full company profile

uuid0000rta

Namestring
Lorient Capital
Legal namestring
Lorient Capital Management, LLC
Websiteurl
lorientcap.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Lorient Capital is a healthcare-focused lower middle market private equity firm founded in 2015 and headquartered in Miami, FL with a secondary office in Birmingham, MI. The firm invests in founder-led and operator-led healthcare businesses at the $5-25M EBITDA entry point, deploying $25-$100M of equity per platform through majority and control structures across buyouts and Executive Partnership builds. Lorient operates three flagship funds with approximately $2 billion in total AUM, with Fund III closing at $500 million in June 2025 on an oversubscribed basis versus its original $350 million target.

The firm's core proprietary assets are L1OS (the Lorient Operating System) and Morpheus, its proprietary data platform. L1OS is a codified operating framework that establishes shared definitions of success, unified planning and execution cadence, accountability structures, and sequenced integration protocols for distributed healthcare operations. Morpheus consolidates operational, financial, workforce, scheduling, workflow, and sector-specific data into a unified architecture, producing weekly role-specific dashboards for executives, regional leaders, managers, and supervisors. The platform supports optimization and anomaly detection use cases across the portfolio.

Lorient's business model is traditional private equity fund management, deriving revenue from management fees on assets under management and carried interest from portfolio company exits. The firm has completed 20 platform investments and 9 realized exits across healthcare sub-sectors including urgent care (American Family Care, Midwest Express Clinic), primary care (Primor Health, Elite Patient Care, Vitae Health Systems), home health and hospice (PurposeCare, Healthy Living Network, Transitions Care), behavioral health (Behavior Frontiers, Centria Healthcare), dental (Reveal Dental Partners), telehealth (PeterMD), workforce solutions (ShiftKey), payments technology (ClearGage), aesthetics (Manor), orthopedic care (The CORE Institute), veterinary (Vet's Best Friend), and career training (MedCerts). The firm is led by Co-Founders and Managing Partners David Berman and Jordan Broome, supported by an integrated team of approximately 11-50 professionals spanning investing, operations, business development, data science, and talent functions.

Short descriptiontext

Lorient Capital is a healthcare-focused lower middle market private equity firm that partners with founder-led and operator-led healthcare businesses, deploying $25-$100M equity per platform and applying its proprietary L1OS operating system and Morpheus data platform across approximately $2 billion in AUM.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private equity, lower middle market investing, growth equity investments, portfolio operations platform, fund management services
Industry1 code
PRIMARYFSANAAAL
Venture Debt Providers
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Other Financial Investment Activities5239
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Private Equity
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Private Equity Fund Management
TypeManaged Services
Description

Lorient operates as a healthcare-focused private equity firm managing three flagship funds. Revenue derived from management fees on assets under management and carried interest from portfolio company exits. Fund III closed at $500 million in total commitments.

lorientcap.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1L1OS
Description

Lorient's proprietary Operating System - a repeatable framework that brings operational discipline to every business they partner with, including shared definitions of success, consistent routines, and dependable ways of working.

lorientcap.com
+1 more record
Core offering1 text field

Lorient Capital is a healthcare-focused private equity firm that invests $25–$100M of equity per platform in founder-led healthcare businesses with $5–25M EBITDA at entry, taking majority or control positions. The firm supports portfolio companies through its proprietary L1OS operating system and Morpheus data platform to standardize workflows, install leadership rhythms, and provide weekly operational visibility across distributed healthcare operations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Sequenced integration enables new business units to achieve standard routines in weeks rather than months compared to initial deployment
+1 more record
Product overview1 text field

Lorient Capital is a private equity firm that offers a unified platform combining L1OS (the Lorient Operating System) and Morpheus, a proprietary data platform. L1OS provides operational discipline through standardized workflows, measurable processes, and traceable decisions, while Morpheus consolidates operational, financial, workforce, scheduling, and sector-specific data into structured dashboards. The platform also includes a portfolio of healthcare services companies across urgent care (American Family Care, Midwest Express Clinic), dental care (Reveal Dental Partners), behavioral health (Behavior Frontiers, Centria Healthcare), home health (PurposeCare, Healthy Living Network, Transitions Care), primary care (Primor Health, Elite Patient Care, Vitae Health Systems), telehealth (PeterMD), workforce solutions (ShiftKey), payments technology (ClearGage), aesthetics (Manor), orthopedic care (The CORE Institute), veterinary care (Vet's Best Friend), and career training (MedCerts).

Product and service3 records
1Lorient Healthcare Fund III
CategoryPrivate Equity Fund
2Lorient Healthcare Fund II
CategoryPrivate Equity Fund
3Lorient Healthcare Fund I
CategoryPrivate Equity Fund
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Lower middle market private equity firm with operating partner support model and healthcare exposure (David Vermiglio, Lorient's CFO/CCO, previously served as VP of Finance at Huron). Comparable in deal size range and operator-supported approach.

TypeDirect peer
Description

Growth-oriented private equity firm with a dedicated healthcare franchise spanning services, technology, and pharma. Comparable healthcare specialization and operator-led value creation approach.

TypeDirect peer
Description

Healthcare-dedicated middle market private equity firm investing in healthcare services and products. Directly comparable given similar sector focus and lower middle market buyout strategy.

TypeDirect peer
Description

Healthcare-focused private equity firm exclusively investing in the healthcare industry across services, products, and distribution. Closely comparable vertical specialization to Lorient.

TypeDirect peer
Description

Lower middle market private equity firm with a healthcare services franchise. Comparable to Lorient in target deal size, healthcare sub-sector orientation, and operator-led value creation.

TypeDirect peer
Description

Lower middle market private equity firm with significant healthcare services activity, executing buy-and-build strategies. Comparable in size, deal profile ($5-25M EBITDA targets), and multi-site healthcare thesis.

TypeDirect peer
Description

One of the most established healthcare-focused private equity firms, investing across healthcare services and technology. Highly comparable to Lorient in vertical specialization and lower middle market orientation, though at materially larger AUM scale.

TypeDirect peer
Description

Healthcare-focused middle market private equity firm investing in healthcare services, pharma services, and medical technology. Closely comparable to Lorient in vertical focus and platform approach to healthcare.

TypeDirect peer
Description

Healthcare-focused private equity firm targeting lower middle market healthcare services and products companies. Closely comparable to Lorient in deal size and sector focus.

TypeBroad incumbent
Description

Large-cap global private equity platform with a dedicated healthcare strategic growth franchise. Comparable in healthcare focus but materially larger scale and broader mandate than Lorient's lower middle market orientation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries20 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment10 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lorient Capital

Healthcare Private Equitylorientcap.com

Lorient Capital is a healthcare-focused lower middle market private equity firm that partners with founder-led and operator-led healthcare businesses, deploying $25-$100M equity per platform and applying its proprietary L1OS operating system and Morpheus data platform across approximately $2 billion in AUM.

What Lorient Capital does

Lorient Capital is a healthcare-focused lower middle market private equity firm founded in 2015 and headquartered in Miami, FL with a secondary office in Birmingham, MI. The firm invests in founder-led and operator-led healthcare businesses at the $5-25M EBITDA entry point, deploying $25-$100M of equity per platform through majority and control structures across buyouts and Executive Partnership builds. Lorient operates three flagship funds with approximately $2 billion in total AUM, with Fund III closing at $500 million in June 2025 on an oversubscribed basis versus its original $350 million target.

The firm's core proprietary assets are L1OS (the Lorient Operating System) and Morpheus, its proprietary data platform. L1OS is a codified operating framework that establishes shared definitions of success, unified planning and execution cadence, accountability structures, and sequenced integration protocols for distributed healthcare operations. Morpheus consolidates operational, financial, workforce, scheduling, workflow, and sector-specific data into a unified architecture, producing weekly role-specific dashboards for executives, regional leaders, managers, and supervisors. The platform supports optimization and anomaly detection use cases across the portfolio.

Lorient's business model is traditional private equity fund management, deriving revenue from management fees on assets under management and carried interest from portfolio company exits. The firm has completed 20 platform investments and 9 realized exits across healthcare sub-sectors including urgent care (American Family Care, Midwest Express Clinic), primary care (Primor Health, Elite Patient Care, Vitae Health Systems), home health and hospice (PurposeCare, Healthy Living Network, Transitions Care), behavioral health (Behavior Frontiers, Centria Healthcare), dental (Reveal Dental Partners), telehealth (PeterMD), workforce solutions (ShiftKey), payments technology (ClearGage), aesthetics (Manor), orthopedic care (The CORE Institute), veterinary (Vet's Best Friend), and career training (MedCerts). The firm is led by Co-Founders and Managing Partners David Berman and Jordan Broome, supported by an integrated team of approximately 11-50 professionals spanning investing, operations, business development, data science, and talent functions.

Lorient Capital firmographics

Firmographics
Name
Lorient Capital
Legal name
Lorient Capital Management, LLC
Website
https://lorientcap.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Lorient Capital is a healthcare-focused lower middle market private equity firm that partners with founder-led and operator-led healthcare businesses, deploying $25-$100M equity per platform and applying its proprietary L1OS operating system and Morpheus data platform across approximately $2 billion in AUM.
Ownership category
akta.pro rank

Lorient Capital industry classification

Industry
Product category
Healthcare Private Equity
NAICS
Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAL
Venture Debt Providers

Keywords

  • Healthcare private equity
  • Lower middle market investing
  • Growth equity investments
  • Portfolio operations platform
  • Fund management services

Where Lorient Capital is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Lorient Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Private Equity Fund Management: Lorient operates as a healthcare-focused private equity firm managing three flagship funds. Revenue derived from management fees on assets under management and carried interest from portfolio company exits. Fund III closed at $500 million in total commitments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Lorient Capital product offering

Product offering

Core offering

Lorient Capital is a healthcare-focused private equity firm that invests $25–$100M of equity per platform in founder-led healthcare businesses with $5–25M EBITDA at entry, taking majority or control positions. The firm supports portfolio companies through its proprietary L1OS operating system and Morpheus data platform to standardize workflows, install leadership rhythms, and provide weekly operational visibility across distributed healthcare operations.

Product overview

Lorient Capital is a private equity firm that offers a unified platform combining L1OS (the Lorient Operating System) and Morpheus, a proprietary data platform. L1OS provides operational discipline through standardized workflows, measurable processes, and traceable decisions, while Morpheus consolidates operational, financial, workforce, scheduling, and sector-specific data into structured dashboards. The platform also includes a portfolio of healthcare services companies across urgent care (American Family Care, Midwest Express Clinic), dental care (Reveal Dental Partners), behavioral health (Behavior Frontiers, Centria Healthcare), home health (PurposeCare, Healthy Living Network, Transitions Care), primary care (Primor Health, Elite Patient Care, Vitae Health Systems), telehealth (PeterMD), workforce solutions (ShiftKey), payments technology (ClearGage), aesthetics (Manor), orthopedic care (The CORE Institute), veterinary care (Vet's Best Friend), and career training (MedCerts).

Differentiator

Problem solved

Functional benefit

Brands

  • L1OS: Lorient's proprietary Operating System - a repeatable framework that brings operational discipline to every business they partner with, including shared definitions of success, consistent routines, and dependable ways of working.
  • Morpheus

Products and services

  • Lorient Healthcare Fund III
  • Lorient Healthcare Fund II
  • Lorient Healthcare Fund I

Quantifiable outcome

  • Sequenced integration enables new business units to achieve standard routines in weeks rather than months compared to initial deployment
  • +1 more outcomes

Companies that use Lorient Capital

Customer profile

Segments4 records

Ideal customer profiles2 records

Lorient Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Lorient Capital partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Lorient Capital competitors and assessment

Company assessment

Direct peers

  • Huron Capital Partners: Lower middle market private equity firm with operating partner support model and healthcare exposure (David Vermiglio, Lorient's CFO/CCO, previously served as VP of Finance at Huron). Comparable in deal size range and operator-supported approach.
  • New Mountain Capital: Growth-oriented private equity firm with a dedicated healthcare franchise spanning services, technology, and pharma. Comparable healthcare specialization and operator-led value creation approach.
  • Linden Capital Partners: Healthcare-dedicated middle market private equity firm investing in healthcare services and products. Directly comparable given similar sector focus and lower middle market buyout strategy.
  • RoundTable Healthcare Partners: Healthcare-focused private equity firm exclusively investing in the healthcare industry across services, products, and distribution. Closely comparable vertical specialization to Lorient.
  • Centre Partners: Lower middle market private equity firm with a healthcare services franchise. Comparable to Lorient in target deal size, healthcare sub-sector orientation, and operator-led value creation.
  • Audax Group: Lower middle market private equity firm with significant healthcare services activity, executing buy-and-build strategies. Comparable in size, deal profile ($5-25M EBITDA targets), and multi-site healthcare thesis.
  • Welsh, Carson, Anderson & Stowe: One of the most established healthcare-focused private equity firms, investing across healthcare services and technology. Highly comparable to Lorient in vertical specialization and lower middle market orientation, though at materially larger AUM scale.
  • Avista Capital Partners: Healthcare-focused middle market private equity firm investing in healthcare services, pharma services, and medical technology. Closely comparable to Lorient in vertical focus and platform approach to healthcare.
  • Petra Capital Partners: Healthcare-focused private equity firm targeting lower middle market healthcare services and products companies. Closely comparable to Lorient in deal size and sector focus.

Broad incumbents

  • KKR Healthcare Strategic Growth: Large-cap global private equity platform with a dedicated healthcare strategic growth franchise. Comparable in healthcare focus but materially larger scale and broader mandate than Lorient's lower middle market orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Lorient Capital social profiles

Digital presence

Lorient Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lorient Capital leadership team

Management profile

Number of profiles

Profiles7 records

Lorient Capital subsidiaries and ownership

Company hierarchy

Subsidiaries20 records

Lorient Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lorient Capital M&A and investment

M&A and investment

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lorient Capital

What does Lorient Capital do?

Lorient Capital is a healthcare-focused private equity firm that invests $25–$100M of equity per platform in founder-led healthcare businesses with $5–25M EBITDA at entry, taking majority or control positions. The firm supports portfolio companies through its proprietary L1OS operating system and Morpheus data platform to standardize workflows, install leadership rhythms, and provide weekly operational visibility across distributed healthcare operations.

Is Lorient Capital a public or private company?

Lorient Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Lorient Capital founded?

Lorient Capital was founded in 2015. It employs 11 to 50 people.

Where is Lorient Capital based?

Lorient Capital is headquartered in Miami, United States, in the North America region.

How does Lorient Capital make money?

One revenue line is on record: private Equity Fund Management.

Who are Lorient Capital's main competitors?

Direct peers on record are Huron Capital Partners, New Mountain Capital, Linden Capital Partners, RoundTable Healthcare Partners, Centre Partners, Audax Group, Welsh, Carson, Anderson & Stowe, Avista Capital Partners and Petra Capital Partners. KKR Healthcare Strategic Growth is listed as a broad incumbent.

Does Lorient Capital have an API?

No public API is recorded for Lorient Capital.

What industry is Lorient Capital in?

Lorient Capital's product category is Healthcare Private Equity. Its primary akta.pro industry code is FSANAAAL, Venture Debt Providers. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ION AnalyticsLorient leverages data to fill operational gaps in healthcareLorient, a healthcare private equity firm, uses its data platform Morpheus and operating system L1OS to improve operational gaps in portfolio companies. Its USD 503m Fund III has made six investments, with two more expected, focusing on lower mid-market healthcare businesses. The firm plans to further invest in AI capability.citybizLorient Opening First New York City Office at 825 Third AvenueLorient, a healthcare-focused investment firm, signed a lease for 5,556 square feet at 825 Third Avenue, its first New York City office. The DurstReady suite is fully furnished and wired for immediate occupancy. The building recently underwent a $150 million renovation.Commercial ObserverHealth Care Investment Firm Lorient Inks 6K-SF lease at Durst’s 825 Third AvenueLorient, a health care investment firm, signed a 5,556-square-foot lease at Durst's 825 Third Avenue in Midtown East. The asking rent was $100 per square foot, above the $85.08 average for Class A space in Midtown. The lease term was not disclosed.Business Wire BlogLorient Opens New York Office, Expanding U.S. FootprintLorient, a healthcare-focused investment firm with about $2 billion in assets under management, opened a new Midtown East office in New York City. The office will initially employ six professionals, with plans to grow to 15-20 employees over two to three years. The firm expects to have over 40 professionals across its three offices by end of 2026.Venture Capital Access OnlinePeterMD and Lorient Partner to Accelerate Growth of the Nation’s First Fully Integrated Medicine 3.0 PlatformLorient and Emanate made a majority equity investment in PeterMD, a direct-to-consumer health platform, to accelerate its expansion in the $200 billion Medicine 3.0 market. The partnership brings David Prokupek to PeterMD's board as Executive Chair. PeterMD serves over 400,000 patients with diagnostics, hormone therapy, and personalized treatments.Business Wire BlogPeterMD and Lorient Partner to Accelerate Growth of the Nation’s First Fully Integrated Medicine 3.0 PlatformLorient and Emanate made a majority equity investment in PeterMD, a direct-to-consumer health platform, to scale its Medicine 3.0 platform. The partnership targets the $200 billion market, with David Prokupek joining the board as Executive Chair. PeterMD serves over 400,000 patients.AijournRise Health Rebrands as Primor Health, Signaling Next Phase of Growth as a Multi-State Primary Care PlatformRise Health, a primary care platform backed by Lorient Capital and Martis Capital, has rebranded as Primor Health, marking its transition from an acquisition-focused growth phase to a performance-driven, clinically integrated platform. The company operates across Nevada, New Mexico, and Texas with nearly 80 providers serving patients through 17 locations, and the new identity is anchored by the Primor Care Model designed to drive performance in both fee-for-service and value-based care arrangements.PR NewswireRise Health Rebrands as Primor Health, Signaling Next Phase of Growth as a Multi-State Primary Care PlatformRise Health has rebranded as Primor Health, marking its transition from an acquisition-focused growth phase to a performance-driven, clinically integrated primary care platform operating across Nevada, New Mexico, and Texas. The company, backed by Lorient Capital and Martis Capital, operates nearly 80 providers across 17 locations and has introduced the Primor Care Model framework to drive performance across both fee-for-service and value-based care. The rebrand is effective immediately, with the new visual identity and brand presence rolling out across all locations in the coming weeks.AbfjournalTPG Twin Brook Agents Two Debt Financing TransactionsTPG Twin Brook served as administrative agent on two separate debt financing transactions supporting private equity activity. The first transaction backed Longshore Capital Partners' leveraged buyout of DemandTec, an AI-powered pricing and trade fund management software provider. The second transaction supported Lorient Capital's recapitalization of American Family Care, a national on-demand urgent care provider.